Gene · 409
Papers2,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pioglitazone Enhances β-Arrestin2 Signaling and Ameliorates Insulin Resistance in Classical Insulin Target Tissues. | Pharmacology | 2021 | 34082428 | PubTator, text mining | PubMed |
| Systems biology approach highlights mechanistic differences between Crohn's disease and ulcerative colitis. | Sci Rep | 2021 | 34075172 | PubTator, text mining | PubMed |
| Advances in Technologies for Highly Active Omega-3 Fatty Acids from Krill Oil: Clinical Applications. | Mar Drugs | 2021 | 34073184 | PubTator, text mining | PubMed |
| Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization. | Int J Mol Sci | 2021 | 34070125 | PubTator, text mining | PubMed |
| GPCRomics of Homeostatic and Disease-Associated Human Microglia. | Front Immunol | 2021 | 34054860 | PubTator, text mining | PubMed |
| Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort. | Nat Med | 2021 | 34045736 | PubTator, text mining | PubMed |
| A20-Binding Inhibitor of Nuclear Factor-κB Targets β-Arrestin2 to Attenuate Opioid Tolerance. | Mol Pharmacol | 2021 | 34031190 | PubTator, text mining | PubMed |
| Can GPCRs Be Targeted to Control Inflammation in Asthma? | Adv Exp Med Biol | 2021 | 34019260 | PubTator, text mining | PubMed |
| Transcriptome responses in polar cod (Boreogadus saida) liver slice culture exposed to benzo[a]pyrene and ethynylestradiol: insights into anti-estrogenic effects. | Toxicol In Vitro | 2021 | 34015484 | PubTator, text mining | PubMed |
| ECM2 and GLT8D2 in human pulmonary artery hypertension: fruits from weighted gene co-expression network analysis. | J Thorac Dis | 2021 | 34012575 | PubTator, text mining | PubMed |
| Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor. | Sci Rep | 2021 | 34012003 | PubTator, text mining | PubMed |
| β-arrestin 2 stimulates degradation of HIF-1α and modulates tumor progression of glioblastoma. | Cell Death Differ | 2021 | 34007068 | PubTator, text mining | PubMed |
| ß-arrestin 2 germline knockout does not attenuate opioid respiratory depression. | Elife | 2021 | 34002697 | PubTator, text mining | PubMed |
| β-Arrestin 2 Regulates Inflammatory Responses against Mycobacterium tuberculosis Infection through ERK1/2 Signaling. | J Immunol | 2021 | 34001657 | PubTator, text mining | PubMed |
| PAR2 promotes high-fat diet-induced hepatic steatosis by inhibiting AMPK-mediated autophagy. | J Nutr Biochem | 2021 | 34000413 | PubTator, text mining | PubMed |
| Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action. | Front Pharmacol | 2021 | 33995107 | PubTator, text mining | PubMed |
| β-Arrestin2 Inhibits the Apoptosis and Facilitates the Proliferation of Fibroblast-like Synoviocytes in Diffuse-type Tenosynovial Giant Cell Tumor. | Cancer Genomics Proteomics | 2021 | 33994368 | PubTator, text mining | PubMed |
| G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis. | Commun Biol | 2021 | 33990686 | PubTator, text mining | PubMed |
| Kisspeptin-54 attenuates oxidative stress and neuronal apoptosis in early brain injury after subarachnoid hemorrhage in rats via GPR54/ARRB2/AKT/GSK3β signaling pathway. | Free Radic Biol Med | 2021 | 33989759 | PubTator, text mining | PubMed |
| Structural insights into ligand recognition and activation of angiotensin receptors. | Trends Pharmacol Sci | 2021 | 33985815 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/409/papers?page=28